FDA declines to approve Orexigen diet drug
Orexigen Therapeutics Inc. shares plunged nearly 75 percent in pre-market trading Tuesday after U.S. health officials declined to approve the experimental weight loss pill Contrave.
View full post on Yahoo! Health News
approve, Declines, Diet, drug, Orexigen